News
RedHill Biopharma Announces the Transfer of its Listing to The Nasdaq Capital Market
RedHill Biopharma Ltd. a specialty biopharmaceutical company, today announced that it has received approval from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) to transfer the listing of the American Depositary Shares (“ADSs”) to the Nasdaq Capital Market.